🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the reactogenicity, safety and imm...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2019-10-25
Trial ID
NCT04006808
Treatments Being Tested
This is a phase 1 study to assess the safety and immunogenicity of differen...
Status
Completed
Location
Josha Research
Start Date
2022-05-30
Trial ID
NCT05228314
A Phase II randomized, double-blind, placebo-controlled study screening app...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
Start Date
2019-09-09
Trial ID
NCT03930745
The purpose of this study is to compare the safety and immunogenicity of a ...
Status
Completed
Location
University of Kentucky
Start Date
2012-04
Trial ID
NCT01585181
The purpose of this study is to see if two new malaria vaccines called FMP1...
Status
Completed
Location
WRAIR Clinical Trials Center
Start Date
2001-04
Trial ID
NCT01556945
Treatments Being Tested
The safety and efficacy of pembrolizumab plus the investigator's choice of ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham-Medicine ( Site 0065)
Start Date
2021-06-18
Trial ID
NCT04895358
Treatments Being Tested
Phase Ib, single centre, double-blind, double-dummy placebo-controlled, ran...
Status
Completed
Location
Hospital Universitario "Dr. José Eleuterio González" de la Universidad Autónoma de Nuevo León.
Start Date
2020-10-23
Trial ID
NCT04440774
The study aims to investigate the safety and immunogenicity of one dose vs ...
Status
Not Yet Recruiting
Location
Health Index Multispecialty Clinic, Barangay Toclong 2B
Start Date
2025-09-01
Trial ID
NCT05633446
The purpose of this first-in-human study is to evaluate the safety and immu...
Status
Terminated
Location
Velocity Clinical Research - Westlake
Start Date
2023-01-23
Trial ID
NCT05701800
P27A study is designed as a randomized phase Ia/Ib trial to evaluate the sa...
Status
Completed
Location
CHUV CRC
Start Date
2014-03
Trial ID
NCT01949909
Treatments Being Tested